George BOBOTAS,Roelof M. Rongen,Egil Bodd,Hogne Vik
申请号：
US14088621
公开号：
US20140080889A1
申请日:
2013.11.25
申请国别(地区):
US
年份:
2014
代理人:
摘要：
A method and composition for lipid therapy. In some embodiments, the method comprises providing a subject group having a baseline triglyceride level of 200 to 499 mg/dl and being at or near its low-density lipoprotein cholesterol (LDL-C) level goal, and reducing the triglyceride level and the non-high-density lipoprotein cholesterol (non-HDL-C) level of the subject group as compared to treatment with a 3-hydroxy-3-methyl glutaryl coenzyme A (HMG CoA) inhibitor alone, by administering to the subject group an effective amount of an HMG CoA inhibitor and a composition comprising omega-3 fatty acids.
